The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs." The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.
Recent comments
3 weeks 2 days ago
4 weeks 2 days ago
4 weeks 2 days ago
5 weeks 5 days ago
10 weeks 6 days ago
13 weeks 2 days ago
18 weeks 2 days ago
30 weeks 2 days ago
32 weeks 3 days ago
33 weeks 3 days ago